TR200102385T2 - Kendiliğinden çözülür N-benzoil staurosporin kompozisyonları. - Google Patents

Kendiliğinden çözülür N-benzoil staurosporin kompozisyonları.

Info

Publication number
TR200102385T2
TR200102385T2 TR2001/02385T TR200102385T TR200102385T2 TR 200102385 T2 TR200102385 T2 TR 200102385T2 TR 2001/02385 T TR2001/02385 T TR 2001/02385T TR 200102385 T TR200102385 T TR 200102385T TR 200102385 T2 TR200102385 T2 TR 200102385T2
Authority
TR
Turkey
Prior art keywords
dissolving
self
compositions
benzoyl
benzoyl staurosporin
Prior art date
Application number
TR2001/02385T
Other languages
English (en)
Turkish (tr)
Inventor
Paul Matthews Graham
Haberlin Barbara
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10847896&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200102385(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TR200102385T2 publication Critical patent/TR200102385T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TR2001/02385T 1999-02-16 2000-02-14 Kendiliğinden çözülür N-benzoil staurosporin kompozisyonları. TR200102385T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9903547.9A GB9903547D0 (en) 1999-02-16 1999-02-16 Organic compounds

Publications (1)

Publication Number Publication Date
TR200102385T2 true TR200102385T2 (tr) 2002-09-23

Family

ID=10847896

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02385T TR200102385T2 (tr) 1999-02-16 2000-02-14 Kendiliğinden çözülür N-benzoil staurosporin kompozisyonları.

Country Status (34)

Country Link
US (3) US20020061873A1 (enExample)
EP (1) EP1152750B1 (enExample)
JP (2) JP5057610B2 (enExample)
KR (2) KR20080064914A (enExample)
CN (1) CN100367930C (enExample)
AR (2) AR022589A1 (enExample)
AT (1) ATE430554T1 (enExample)
AU (1) AU765776B2 (enExample)
BR (1) BRPI0008228B8 (enExample)
CA (1) CA2362277C (enExample)
CL (1) CL2009001682A1 (enExample)
CZ (1) CZ303979B6 (enExample)
DE (1) DE60042151D1 (enExample)
DK (1) DK1152750T3 (enExample)
EC (1) ECSP083351A (enExample)
ES (1) ES2326783T3 (enExample)
GB (1) GB9903547D0 (enExample)
HK (1) HK1045807B (enExample)
HU (1) HUP0105364A3 (enExample)
ID (1) ID30504A (enExample)
IL (3) IL144512A0 (enExample)
MY (1) MY128362A (enExample)
NO (1) NO331232B1 (enExample)
NZ (1) NZ513529A (enExample)
PE (1) PE20001499A1 (enExample)
PL (1) PL198330B1 (enExample)
PT (1) PT1152750E (enExample)
RU (1) RU2266121C2 (enExample)
SI (1) SI1152750T1 (enExample)
SK (1) SK286967B6 (enExample)
TR (1) TR200102385T2 (enExample)
TW (1) TWI240636B (enExample)
WO (1) WO2000048571A1 (enExample)
ZA (1) ZA200106677B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7795246B2 (en) 1998-08-06 2010-09-14 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
US6200968B1 (en) * 1998-08-06 2001-03-13 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
BR0208306A (pt) * 2001-03-26 2004-03-09 Novartis Ag Composições farmacêuticas
PL392652A1 (pl) 2001-05-16 2010-12-06 Novartis Ag Kombinacja zawierająca N-{5-[4-(4-metylo-piperazyno-metylo)-benzoiloamido]-2-metylofenylo}-4-(3-pirydylo)-2-pirymidyno-aminę oraz środek chemoterapeutyczny, jej zastosowanie, kompozycja farmaceutyczna ją zawierająca oraz zestaw zawierający taką kombinację
EP1441737B1 (en) 2001-10-30 2006-08-09 Novartis AG Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity
GB0206215D0 (en) 2002-03-15 2002-05-01 Novartis Ag Organic compounds
US20060115500A1 (en) * 2002-07-23 2006-06-01 Jithan Aukunuru Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
TWI324604B (en) * 2003-06-18 2010-05-11 Novartis Ag New use of staurosporine derivatives
GB0512324D0 (en) 2005-06-16 2005-07-27 Novartis Ag Organic compounds
GB0419159D0 (en) * 2004-08-27 2004-09-29 Novartis Ag Organic compounds
GT200500310A (es) * 2004-11-19 2006-06-19 Compuestos organicos
WO2008021347A2 (en) * 2006-08-16 2008-02-21 Novartis Ag Method for making solid dispersions of highly crystalline therapeutic compounds
FR2918566B1 (fr) 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
WO2009067221A2 (en) * 2007-11-20 2009-05-28 Cephalon, Inc. Microemulsion containing indolocarbazole compound and dosage forms containing the same
EP2229936B1 (en) * 2009-03-09 2015-05-06 PharmaSol GmbH Nanonized testosterone formulations for improved bioavailability
WO2011000811A2 (en) * 2009-06-30 2011-01-06 Novartis Ag Organic compounds
AU2010335654B2 (en) * 2009-12-22 2015-04-09 Leo Pharma A/S Cutaneous composition comprising vitamin D analogue and a mixture of solvent and surfactants
JO3337B1 (ar) * 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
US9387446B2 (en) * 2011-09-22 2016-07-12 Ariel-University Research And Development Company Ltd. Emulsions and methods of making emulsions
RU2742650C2 (ru) * 2015-12-09 2021-02-09 Фосфейдженикс Лимитед Фармацевтический состав
CN108601732A (zh) 2015-12-09 2018-09-28 磷肌酸有限公司 药物制剂
IL267006B2 (en) 2016-12-21 2024-11-01 Phosphagenics Ltd Process for phosphorylation of a complex alcohol with p4o10 at high temperatures, and products thereof
EP4058465A1 (en) 2019-11-14 2022-09-21 Cohbar Inc. Cxcr4 antagonist peptides

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963367A (en) 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
US4735939A (en) * 1987-02-27 1988-04-05 The Dow Chemical Company Insecticidal activity of staurosporine
US5093330A (en) * 1987-06-15 1992-03-03 Ciba-Geigy Corporation Staurosporine derivatives substituted at methylamino nitrogen
DE3824034C1 (enExample) * 1988-07-15 1989-09-14 Gustav 7290 Freudenstadt De Memminger
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
CA2108266C (en) * 1991-04-19 2003-06-03 Albert J. Owen Convertible microemulsion formulations
GB9113872D0 (en) 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
PT589843E (pt) * 1992-09-25 2002-04-29 Novartis Ag Composicoes farmaceuticas contendo ciclosporinas
US6306421B1 (en) * 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) * 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
US5639474A (en) * 1993-07-01 1997-06-17 Hanmi Pharm. Ind., Ltd. Cyclosporin soft capsule composition
AU692506B2 (en) * 1993-11-17 1998-06-11 Ibah, Inc. Transparent liquid for encapsulated drug delivery
GB9325395D0 (en) * 1993-12-11 1994-02-16 Ciba Geigy Ag Compositions
AU1911095A (en) * 1994-02-18 1995-09-04 Cephalon, Inc. Aqueous indolocarbazole solutions
AU2565895A (en) * 1994-06-01 1995-12-21 Ciba-Geigy Ag Indolocarbazole derivatives for sensitizing multidrug-resistant cells to antitumor agents
GB2308545B (en) 1994-10-26 1999-06-02 Novartis Ag Pharmaceutical microemulsion preconcentrates
MY129435A (en) * 1994-10-26 2007-04-30 Novartis Ag Pharmaceutical microemulsion preconcentrates
EP0711556A1 (de) * 1994-11-09 1996-05-15 Ciba-Geigy Ag Intravenöse Lösungen für ein Staurosporinderivat
EP0733372A3 (de) * 1995-03-21 1998-05-20 Ciba-Geigy Ag Pharmazeutische Formulierungsgrundlage für Nanosuspensionen
AU4491697A (en) 1996-09-27 1998-04-17 Trega Biosciences, Inc. Compositions of therapeutic agents suitable for oral administration
DE19641672A1 (de) 1996-10-10 1998-04-16 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen auf der Basis von ethylenoxidfreien und propylenoxidfreien Emulgatoren zur Herstellung von Mikroemulsionsgelen
US5827522A (en) 1996-10-30 1998-10-27 Troy Corporation Microemulsion and method
NZ314060A (en) 1997-01-13 1997-08-22 Bernard Charles Sherman Pharmaceutical microemulsion preconcentrate comprising cyclosporin dissolved in a solvent system comprising hydrophobic solvent(s) and surfactant(s)
KR20040004416A (ko) * 1997-01-30 2004-01-13 노파르티스 아게 오일을 함유하지 않은 사이클로스포린 ａ 함유 제약 조성물
CA2294031E (en) 1997-07-29 2012-04-03 Pharmacia & Upjohn Company Self-emulsifying formulation for lipophilic compounds
AU728695B2 (en) 1997-07-29 2001-01-18 Boehringer Ingelheim International Gmbh Self-emulsifying formulation for lipophilic compounds
US6346511B1 (en) * 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6979456B1 (en) * 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
GB9814527D0 (en) * 1998-07-03 1998-09-02 Cyclacel Ltd Delivery system
AR013276A1 (es) 1998-07-31 2000-12-13 Panacea Biotec Ltd Composicion de ciclosporina transparente
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Also Published As

Publication number Publication date
CN100367930C (zh) 2008-02-13
NO331232B1 (no) 2011-11-07
PL350556A1 (en) 2002-12-16
KR20080064914A (ko) 2008-07-09
TWI240636B (en) 2005-10-01
RU2266121C2 (ru) 2005-12-20
ES2326783T3 (es) 2009-10-20
US8722664B2 (en) 2014-05-13
CA2362277A1 (en) 2000-08-24
EP1152750A1 (en) 2001-11-14
SK11722001A3 (sk) 2001-12-03
CN1339963A (zh) 2002-03-13
JP2012111763A (ja) 2012-06-14
CA2362277C (en) 2010-03-30
IL144512A (en) 2011-03-31
HK1045807B (zh) 2008-12-05
BRPI0008228B8 (pt) 2021-05-25
MY128362A (en) 2007-01-31
GB9903547D0 (en) 1999-04-07
ZA200106677B (en) 2003-01-14
AU765776B2 (en) 2003-10-02
SI1152750T1 (sl) 2009-10-31
JP5057610B2 (ja) 2012-10-24
US20140056974A1 (en) 2014-02-27
DE60042151D1 (de) 2009-06-18
AR082579A2 (es) 2012-12-19
CL2009001682A1 (es) 2010-07-23
KR100880859B1 (ko) 2009-01-30
PL198330B1 (pl) 2008-06-30
WO2000048571A1 (en) 2000-08-24
NZ513529A (en) 2003-10-31
NO20013964D0 (no) 2001-08-15
PT1152750E (pt) 2009-08-07
ATE430554T1 (de) 2009-05-15
AU3154200A (en) 2000-09-04
CZ20012931A3 (cs) 2001-11-14
HUP0105364A3 (en) 2003-02-28
HUP0105364A2 (hu) 2002-05-29
US20020061873A1 (en) 2002-05-23
ECSP083351A (es) 2008-08-29
HK1045807A1 (zh) 2002-12-13
DK1152750T3 (da) 2009-08-24
CZ303979B6 (cs) 2013-07-31
AR022589A1 (es) 2002-09-04
ID30504A (id) 2001-12-13
KR20010093281A (ko) 2001-10-27
IL192666A0 (en) 2009-02-11
JP2002537242A (ja) 2002-11-05
IL144512A0 (en) 2002-05-23
US20080070897A1 (en) 2008-03-20
SK286967B6 (sk) 2009-08-06
BR0008228A (pt) 2001-10-30
PE20001499A1 (es) 2001-01-12
EP1152750B1 (en) 2009-05-06
BRPI0008228B1 (pt) 2016-08-23
NO20013964L (no) 2001-10-15
US8575147B2 (en) 2013-11-05

Similar Documents

Publication Publication Date Title
TR200102385T2 (tr) Kendiliğinden çözülür N-benzoil staurosporin kompozisyonları.
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
TR200002299T2 (tr) Epotilon kompozisyonları.
IL131651A0 (en) A pharmaceutical formulation containing benzimidazoles with amino acid/caclodextrin combinations and a process for producing the same
WO2000040203A3 (en) Polymeric delivery agents and delivery agent compounds
TR200103574T2 (tr) Amid ikameli/katkılı imidazokinolinler
CY1112606T1 (el) Διαλυμα αριπριπραζολης για χορηγηση εκ του στοματος
AU2274201A (en) Compounds and compositions for delivering active agents
DE69916486D1 (de) Nicotin enthaltende pharmazeutische zusammensetzungen mit schneller transmukosaler absorption
MXPA05001607A (es) Forma galenica para suministro de ingredientes activos dirigido al colon.
PL347671A1 (en) Compounds and compositions for delivering active agents
PT1317419E (pt) Compostos e composições de ácido cianofenoxicarboxílico para administrar agentes activos
TR200103606T2 (tr) Laktik Asit Bakterisi Kombinasyonu ve Kullanımı
CY1105953T1 (el) Συνθεσεις για απελευθερωση συνδυασμων φαρμακων
TR200000635T2 (tr) Levosimendan'ın oral kompozisyonları.
BE2011C013I2 (enExample)
TR200100054T2 (tr) Paroksetin metansülfonat
AP9801253A0 (en) 9-Oxime erythromycin derivatives.
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
TR200103460T2 (tr) 5-Fenil-pirimidin türevleri
DE69914934D1 (de) Stabile wässrige insulinzubereitungen ohne phenol und kresol
EE200200471A (et) Farmatseutiline kompositsioon, mis sisaldab kamptotetsiini või selle derivaati kombinatsioonis pürimidiini derivaadiga ning on ette nähtud vähktõve raviks
MXPA02009552A (es) Derivados de imidazopiridina alquilada.
EP1084710A4 (en) DRUGS AGAINST MALE STERILITY
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.